on Applied DNA Sciences, Inc.
Applied DNA Sciences Regains Compliance with Nasdaq's Minimum Bid Price Rule
Applied DNA Sciences, Inc., a company specializing in PCR-based DNA technologies, announced it successfully regained compliance with the Nasdaq's minimum bid price requirement. After previously failing to maintain a minimum $1.00 bid price, Applied DNA's shares maintained or exceeded this threshold for 10 consecutive business days from April 25 to May 8, 2024, satisfying Nasdaq's standards.
R. H.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Applied DNA Sciences, Inc. news